dc.contributor.author | Næsgaard, Patrycja | |
dc.contributor.author | Grundt, Heidi | |
dc.contributor.author | Nordøy, Arne | |
dc.contributor.author | Staines, Harry | |
dc.contributor.author | Nilsen, Dennis W.T. | |
dc.date.accessioned | 2018-03-06T11:47:51Z | |
dc.date.available | 2018-03-06T11:47:51Z | |
dc.date.issued | 2017-07-24 | |
dc.description.abstract | Background: <br> Fish is the natural dietary source of vitamin D. Reports on the influence of purified omega-3 fatty acids on its uptake are scarce. <br> Objectives: <br> We investigated the impact of a purified high-dose omega-3 compound compared to corn oil on 25-hydroxyvitamin D [25(OH)D] levels following an acute myocardial infarction. <br> Methods: <br> 228 patients were randomized 1:1 to receive a daily dose of either 4 g omega-3 (OMACOR®) or an equal dose of corn oil, administered double-blindly for 12 months. Total omega-3 and omega-6 measurements were available in 40 randomly picked patients. <br> Results: <br> There was no significant intergroup difference in 25(OH)D changes at 12 months follow-up (p = 0.12), but there was a minor statistical significant intragroup increase in 25(OH)D in both intervention arms (p < 0.001 for n-3 polyunsaturated fatty acids and p = 0.013 for corn oil, respectively). A positive correlation was noted between 25(OH)D and omega-3 prior to inclusion; r = 0.418, p = 0.007, attenuated at 12 months by purified omega-3 intervention; r = 0.021, p = 0.93. No positive correlation was observed between omega-6 and 25(OH)D. <br> Conclusion: <br> Long-term treatment with a high dose of purified omega-3 as compared to corn oil did not improve serum concentrations of vitamin D. | en_US |
dc.description.sponsorship | Helse Stavanger HF: ? | en_US |
dc.description | <a href=https://doi.org/10.3389/fcvm.2017.00041> https://doi.org/10.3389/fcvm.2017.00041 </a> | en_US |
dc.identifier.citation | Næsgaard, P., Grundt, H., Nordøy, A., Staines, H. & Nilsen, D. W. T. (2017) Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine, 4. 1-6. https://doi.org/10.3389/fcvm.2017.00041 | en_US |
dc.identifier.cristinID | FRIDAID 1515664 | |
dc.identifier.doi | 10.3389/fcvm.2017.00041 | |
dc.identifier.issn | 2297-055X | |
dc.identifier.uri | https://hdl.handle.net/10037/12263 | |
dc.language.iso | eng | en_US |
dc.publisher | Frontiers Media | en_US |
dc.relation.journal | Frontiers in Cardiovascular Medicine | |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771 | en_US |
dc.subject | VDP::Midical sciences: 700::Clinical medical sciences: 750::Cardiology: 771 | en_US |
dc.subject | Prognose / Prognosis | en_US |
dc.title | Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction. | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |